Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Results for “Advanced or Metastatic NRAS-mutant Melanoma”

5 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Looking for participantsNCT06346067

What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

Who this might be right for

Advanced or Metastatic NRAS-mutant Melanoma

Erasca, Inc. 470

Early research (Phase 1)Ended earlyNCT02974725

What this trial is testing

A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma

Who this might be right for

Non-Small Cell Lung CancerMelanoma

Novartis Pharmaceuticals 241

Testing effectiveness (Phase 2)Study completedNCT01320085

What this trial is testing

A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma

Who this might be right for

BRAF or NRAS Mutant Metastatic Melanoma

Pfizer 183

Testing effectiveness (Phase 2)Study completedNCT01781572

What this trial is testing

A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma

Who this might be right for

Locally Advanced or Metastatic NRAS Mutant Melanoma

Pfizer 102

Testing effectiveness (Phase 2)Study completedNCT06208124

What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for

Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more

Immuneering Corporation 30